Drugs / Tears Naturale Forte
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT03211351 | Jul → Dec 2017 | dry eye syndrome | Huaxia Eye Hospital Group | Completed | No outcome recorded |
| — | NCT02992392 | Dec 2016 → May 2017 | dry eye syndrome | Sun Yat-sen University | Unknown | No outcome recorded |
| — | NCT02817191 | Jun → Nov 2016 | senile cataract | Sun Yat-sen University | Unknown | No outcome recorded |
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT03434106 Background | Feb → May 2018 | Sjogren syndrome | LanZhou University | Unknown | No outcome recorded |
| — | NCT03060005 Background | May → Aug 2017 | Sjogren syndrome | Tung Wah Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tears Naturale Forte | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02817191 ↗ |
| Route | Other | “The patients were administrated Tears Naturale Forte eye drop four times a day after Phaco+IOL” NCT02817191 ↗ |